Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2012

01.05.2012 | Rapid Communication

Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation

verfasst von: Enrico Cappelli, Donatella Vecchio, Guido Frosina

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Glioblastoma multiforme (WHO grade IV) is a highly lethal brain tumor. Its malignancy is in part due to cell populations refractory to radiotherapy and chemotherapy, which in some patients display stem properties (glioma stem cells—GSC). We and others have recently shown that a major mechanism of resistance of GSC to therapies resides in their slow proliferation that in turn is linked to constitutive activation of the DNA damage response. FancD2, a central player of the Fanconi anemia pathway, is induced when replication forks stall at DNA damage sites.

Methods

We have analyzed the kinetics of FancD2 induction in two glioma cell lines with pronounced (Borru) and poor (DR177) stem phenotypes, by fluorescence analysis of nuclear foci.

Results

FancD2 activation was significantly delayed in Borru, consistent with the slow replication fork progression in these cells. On the contrary, no significant difference between Borru and DR177 was observed for pH2AX nuclear foci formation that hallmarks a number of DNA structure variations including double-strand breaks.

Conclusion

GSC display reduced FancD2 activation following radiation damage, most probably due to their elongated cell cycle.
Literatur
Zurück zum Zitat Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884–8896PubMedCrossRef Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884–8896PubMedCrossRef
Zurück zum Zitat Bogliolo M, Lyakhovich A, Callen E, Castella M, Cappelli E, Ramirez MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, Surralles J (2007) Histone H2AX and fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J 26:1340–1351PubMedCrossRef Bogliolo M, Lyakhovich A, Callen E, Castella M, Cappelli E, Ramirez MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, Surralles J (2007) Histone H2AX and fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J 26:1340–1351PubMedCrossRef
Zurück zum Zitat Bolderson E, Richard DJ, Zhou BB, Khanna KK (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 15:6314–6320PubMedCrossRef Bolderson E, Richard DJ, Zhou BB, Khanna KK (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 15:6314–6320PubMedCrossRef
Zurück zum Zitat Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T, Okano H (2000) Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139–153PubMedCrossRef Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T, Okano H (2000) Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139–153PubMedCrossRef
Zurück zum Zitat Moldovan GL, D’Andrea AD (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43:223–249PubMedCrossRef Moldovan GL, D’Andrea AD (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43:223–249PubMedCrossRef
Zurück zum Zitat Raso A, Vecchio D, Cappelli E, Ropolo M, Poggi A, Nozza P, Biassoni R, Mascelli S, Capra V, Kalfas F, Severi P, Frosina G (2012) Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double strand breaks-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol. doi:10.1111/j.1750-3639.2012.00566.x Raso A, Vecchio D, Cappelli E, Ropolo M, Poggi A, Nozza P, Biassoni R, Mascelli S, Capra V, Kalfas F, Severi P, Frosina G (2012) Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double strand breaks-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol. doi:10.​1111/​j.​1750-3639.​2012.​00566.​x
Zurück zum Zitat Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, Poggi A, Cappelli E, Zona G, Spaziante R, Corte G, Frosina G (2009) Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol Cancer Res 7:383–392PubMedCrossRef Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, Poggi A, Cappelli E, Zona G, Spaziante R, Corte G, Frosina G (2009) Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol Cancer Res 7:383–392PubMedCrossRef
Zurück zum Zitat Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D’Andrea AD (2002) S-phase-specific interaction of the fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414–2420PubMedCrossRef Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D’Andrea AD (2002) S-phase-specific interaction of the fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414–2420PubMedCrossRef
Zurück zum Zitat Tumini E, Plevani P, Muzi-Falconi M, Marini F (2011) Physical and functional crosstalk between fanconi anemia core components and the GINS replication complex. DNA Repair (Amst) 10:149–158CrossRef Tumini E, Plevani P, Muzi-Falconi M, Marini F (2011) Physical and functional crosstalk between fanconi anemia core components and the GINS replication complex. DNA Repair (Amst) 10:149–158CrossRef
Zurück zum Zitat Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193PubMedCrossRef Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193PubMedCrossRef
Zurück zum Zitat Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, Lei T (2010) The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol 20:877–889PubMed Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, Lei T (2010) The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol 20:877–889PubMed
Zurück zum Zitat Yuan F, El Hokayem J, Zhou W, Zhang Y (2009) FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J Biol Chem 284:24443–24452PubMedCrossRef Yuan F, El Hokayem J, Zhou W, Zhang Y (2009) FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J Biol Chem 284:24443–24452PubMedCrossRef
Metadaten
Titel
Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation
verfasst von
Enrico Cappelli
Donatella Vecchio
Guido Frosina
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2012
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-012-1217-z

Weitere Artikel der Ausgabe 5/2012

Journal of Cancer Research and Clinical Oncology 5/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.